Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Carlsberg A/S has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners across 2 art units, so each matter has a distinct examiner and technical examination context.
IBRAHIM, MEDINA AHMED is the busiest examiner, with 1 pending matter. Counsel should manage responses separately while coordinating portfolio-level claim and argument positions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IBRAHIM, MEDINA AHMED | 1 | 87.4% | +12.2% |
| KEOGH, MATTHEW R | 1 | 78.5% | +14.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18955685 | Methods for Preparing Mutant Plants | IBRAHIM, MEDINA AHMED | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18844546 | Modulation of Protein Levels | KEOGH, MATTHEW R | 60d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18844546 | Modulation of Protein Levels | KEOGH, MATTHEW R | 60d |
| 18955685 | Methods for Preparing Mutant Plants | IBRAHIM, MEDINA AHMED | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18955685 | Methods for Preparing Mutant Plants | IBRAHIM, MEDINA AHMED | 1662 | §112Other | Non-Final OA | — | Pending | Nov 21, 2024 |
| 18844546 | Modulation of Protein Levels | KEOGH, MATTHEW R | 1663 | §102§103 | Final Rejection | 60d | Pending | Sep 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCarlsberg A/S has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Medina Ahmed Ibrahim has the most, with 1 of Carlsberg A/S's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
